Several pharmaceutical and healthcare-related companies listed on the Nigerian Exchange (NGX) have recorded significant changes in their market valuations, bringing greater attention to the executives responsible for their financial management.
A review of the sector’s leading listed companies, ranked by market capitalisation as of October 23, 2026, highlights finance professionals with experience in accounting, taxation, investment banking, corporate finance and manufacturing.
At Juli Plc, Osho Olaniyi Thomas serves as Chief Financial Officer. A Fellow of the Institute of Chartered Accountants of Nigeria, he also holds a Master of Business Administration degree. His position has been reflected in the company’s financial statements, where he has participated in the formal certification of its financial reports.
Juli operates in pharmaceutical distribution and other consumer-related businesses. Its financial performance remained under pressure in the first half of 2026, with revenue falling to N146.86 million from N269.25 million in the corresponding period of 2025. However, the company reduced its loss after tax from N31.54 million to N12.86 million, representing an improvement of about 59 per cent.
At the October 23 valuation date used in the ranking, Juli had a market capitalisation of approximately N1.31 billion.
Nonye Offorjamah is the Head of Finance at Neimeth International Pharmaceuticals Plc. She brings experience in accounting, taxation, financial reporting and corporate management, having spent several years at May & Baker Nigeria before joining the Simba Group in 2024.
She began her professional career as a tax trainee at KPMG Nigeria in 2001 and later worked at Microdigits. During her time at May & Baker, she held finance and tax-related responsibilities, including accounts payable management and subsidiary accounting. She joined Neimeth in September 2024.
Offorjamah holds a Higher National Diploma in Accountancy from Ondo State Polytechnic, now Rufus Giwa Polytechnic. She is a Fellow of ICAN and an associate member of the Chartered Institute of Taxation of Nigeria.
Neimeth recorded revenue of approximately N3.66 billion in the first half of 2026, compared with N2.91 billion in the corresponding period of 2025. Profit after tax increased slightly to N207.66 million from N203.76 million.
The company’s market capitalisation stood at approximately N34.67 billion as of October 23, according to the figures used in the ranking.
May & Baker Nigeria Plc’s finance operations are led by Ayodeji Aboderin, its Executive Director of Finance. He has built a career spanning the pharmaceutical, manufacturing, food and beverage sectors, with previous roles at PZ Cussons Nigeria, Dansa Foods and Nigerian Bottling Company.
Aboderin joined May & Baker in 2014 and has served as Executive Director of Finance. He holds an accountancy qualification from The Polytechnic, Ibadan, and is a Fellow of ICAN. His professional credentials also include qualifications and memberships associated with management accounting and financial management.
May & Baker reported a 51 per cent increase in profit before tax to N4.85 billion in the first half of 2026, compared with N3.21 billion in the same period a year earlier. The improvement was supported by stronger operating performance, cost management and higher interest income.
Its market capitalisation was estimated at N68.58 billion on October 23.
At MeCure Industries Plc, Ifedamola Oluwasegun F. serves as Group Chief Financial Officer of MeCure Group, with responsibility for the financial operations of MeCure Industries and MeCure Healthcare.
He assumed the role in December 2021 after gaining experience in investment banking, trade finance and corporate strategy. His previous appointments included a senior associate position at Platform Capital Investment Partners and work in trade finance at Access Bank.
Oluwasegun also co-founded Nokkubo.com and holds a Master of Science degree in Finance, Accounting and Management from the University of Bradford. He completed the Chief Executive Programme at Lagos Business School in 2023.
MeCure Industries recorded a 20.4 per cent increase in revenue to N44.85 billion in the first half of 2026. Operating profit rose by 41 per cent to N10.90 billion. However, finance costs climbed by 54.9 per cent to N5.93 billion, highlighting the financial pressure associated with the company’s expansion and borrowing requirements.
MeCure Industries had an estimated market capitalisation of N224.80 billion as of October 23.
Fidson Healthcare Plc’s finance function is led by Imokha Ayebae, who serves as Executive Director in charge of Finance. He joined the company in 2013 as Corporate Finance and Treasury Manager before taking on wider responsibilities within its finance and accounts operations.
Before joining Fidson, Ayebae worked at FBN Capital, where he gained experience in financial advisory services. His earlier career included project management work in the United Kingdom and management consulting.
He holds a Master of Science degree in Business Administration, Management and Operations from the University of Warwick, as well as a Bachelor of Engineering degree in Electronic Systems Engineering from the University of Manchester.
Fidson recorded revenue of N74.48 billion in the first half of 2026, an increase of 18.9 per cent compared with the corresponding period of 2025. Profit after tax rose by 28.2 per cent to N7.72 billion.
However, trade receivables increased significantly to N26.34 billion, drawing attention to the importance of customer collections and working-capital management even as the company reported stronger earnings.
Fidson’s market capitalisation was approximately N250 billion as of October 23.
Olusola Adeyinka is the Chief Financial Officer of Pharma-Deko Plc. He joined the company’s finance team in 2025, bringing more than 25 years of experience in accounting, auditing and financial management.
He began his career at Toye Okedara & Co., a chartered accounting firm in Port Harcourt, where he completed his National Youth Service Corps programme and subsequently worked as an Audit Senior.
His professional experience also covers manufacturing, mining, quarrying, oil and gas. Adeyinka graduated in Accountancy from Ogun State Polytechnic, Abeokuta, in 1995, and became an associate member of ICAN in 2009 before being elevated to Fellow.
His areas of expertise include financial reporting, production costing, taxation, treasury management and corporate financial strategy.
Pharma-Deko had an estimated market capitalisation of N396.78 million as of October 23, 2026.
At Industrial and Medical Gases Nigeria Plc, Gbenga Oladeinde is identified as Financial Controller. However, publicly available information on his educational background, professional qualifications and previous career appointments remains limited, making it difficult to provide a detailed profile.
Olajide Adedayo Abioye is the Financial Controller of Morison Industries Plc. The company’s financial filings identify him in that role, including in documents submitted to the Nigerian Exchange. Publicly available information about his wider professional history and educational background is also limited.
The executives highlighted across these companies illustrate the range of financial responsibilities required to operate in Nigeria’s pharmaceutical and healthcare markets. Their work spans financial reporting, cost management, taxation, funding, investment planning and corporate governance.
With rising production costs and financing demands continuing to shape the sector, their ability to protect cash flow, improve operational efficiency and support sustainable growth will remain important to the performance of the companies they serve.
Reporting by TalkNaijaMedia
Reader Comments (0)
No comments yet. Be the first to share your perspective on this report.